LONA Market Cap History — LeonaBio Capitalization Over Time

As of 5/5/2026 LeonaBio has a market cap of 90.46 million. Investors often follow the LONA market cap history to compare the size of the company over time.

This page shows LONA market capitalization trends over time, with 3 market cap datapoints presented, dating back to 11/5/2025.

Quick links: Market Cap History Table  |  Market Cap History Chart  |  About LeonaBio
LONA Market Cap History



Below is a table of the LONA market cap history going back to 11/5/2025:

Date LONA Market Cap
11/5/202516.52M
3/27/202684.26M
5/5/202690.46M

Also see: LONA Shares Outstanding History
and LONA YTD Return
LONA Historical Market Cap:
+907.26% CAGR
LONA Historical Market Cap: +907.26% CAGR

Mouse over chart for data details
11/5/20253/27/20265/5/2026
Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company. It focuses on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline consists of both blood brain barrier permeable and peripherally restricted drug candidates for the central nervous system (CNS), peripheral nervous system, and other indications. Its lead candidate, fosgonimeton (ATH-1017), is a subcutaneously administered, small molecule positive modulator of the hepatocyte growth factor/mesenchymal-epithelial transition factor (HGF/MET) system for CNS disorders. We show 3 historical shares outstanding datapoints in our LONA shares outstanding history coverage, used to compute LONA market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing LONA market cap history over the course of time is important for investors interested in comparing LONA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of LONA versus a peer is one thing; comparing LONA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like LONA can fluctuate over the course of history. With this page we aim to empower investors researching LONA by allowing them to research the LONA market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree LONA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap
LeonaBio (LONA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

LOXO Market Cap History
LPCN Market Cap History
LPNT Market Cap History
LPTX Market Cap History
LQDA Market Cap History
LRMR Market Cap History
LSTA Market Cap History
LTRN Market Cap History
LUCD Market Cap History
LUMO Market Cap History
More Healthcare companies »
 

LONA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.